[Summary]

As of 18:23 on June 1, 2026, there were 6 regular earnings releases and 8 correction, re-correction, or prior-period correction disclosures.

There are three main points today.

First is Ito En’s full-year earnings. Sales rose to 497.877 billion yen, but operating profit declined to 21.684 billion yen and net profit fell sharply to 3.466 billion yen. This is not a simple sales-growth story. Profit margin, one-off factors, and cash quality matter.

Second is People’s first quarter. Sales were 267 million yen and operating loss was 57 million yen. The loss narrowed from the prior year, but sales remain weak, and a toy company with heavy year-end seasonality should not be judged by Q1 alone.

Third is the content of correction disclosures. Redax, Kandenko, Trade Works, Softtex, Geniee, Japan Material, and MUSCAT GROUP are among the names, but the severity differs greatly. Geniee revised revenue, operating profit, profit, and EPS downward. Redax also revised operating profit, ordinary profit, net profit, and EPS downward after additional expense recognition.

Disclosures Covered

The 14 target disclosures on June 1 were as follows.

TimeCodeNameDisclosureView
18:007602RedaxCorrection and numerical data correctionAdditional expenses lowered operating profit and net profit
16:30195AMUSCAT GROUPCorrection and impairment loss794 million yen impairment on affiliate shares; operating CF also corrected
16:007865PeopleFY2027/1 Q1Sales down, operating loss narrowed
15:301942KandenkoCorrectionComprehensive income aggregation corrected; major profit lines unchanged
15:302593Ito EnFY2026/4 full yearSales up, operating profit down, net profit sharply down
15:303997Trade WorksPrior-period correctionReclassification of capital surplus and non-controlling interests
15:303997Trade WorksEarnings correctionNo P/L impact
15:30550ASofttexRe-correctionTotal assets and equity ratio corrected
15:306562GenieeCorrectionRevenue, operating profit, and EPS revised down
13:001480NF Enterprise ValueETF resultsNet assets 15.690 billion yen; distribution 330 yen
13:002251JGB Double InverseETF interim resultsNet assets 6.246 billion yen; units doubled
13:002518NF Japan Equity Women EmpowermentETF resultsNet assets 14.395 billion yen; NAV up
13:002643Japan Equity Select ETFETF resultsNAV up, units down
10:306055Japan MaterialCorrectionSegment description corrected; financial figures unchanged

Six Regular Earnings Releases, Two Operating Companies

The regular earnings releases consisted of Ito En and People, plus four ETFs.

NameEarningsMain figuresView
Ito En (2593)FY2026/4 full yearSales 497.877 billion yen, operating profit 21.684 billion yenSales up, operating profit down, net profit sharply down
People (7865)FY2027/1 Q1Sales 267 million yen, operating loss 57 million yenLoss narrowed but sales remain weak
NF Enterprise Value (1480)ETF resultsNet assets 15.690 billion yenNAV and distribution rose
JGB Double Inverse (2251)ETF interim resultsNet assets 6.246 billion yenUnits doubled, suggesting rate-hedge demand
NF Japan Equity Women Empowerment (2518)ETF resultsNet assets 14.395 billion yenNAV and assets rose
Japan Equity Select ETF (2643)ETF resultsNet assets 2.038 billion yenNAV rose, units declined

Ito En showed sales growth without profit growth. Operating profit fell 5.6% year on year and net profit fell 75.5%. For a large beverage company, sales scale is meaningful, but the market needs to see where margins were lost: pricing, raw materials, promotion, overseas business, or special items.

People looked weak on Q1 alone, with sales down 7.8% year on year and an operating loss. But the operating loss narrowed from 82 million yen to 57 million yen. Because toy companies are seasonal and depend heavily on the year-end selling season, the next question is progress toward first-half guidance.

Ito En: Quality Of Profit Matters More Than Sales

Ito En’s headline looks like higher sales.

Sales              497.877 billion yen (+5.3%)
Operating profit    21.684 billion yen (-5.6%)
Ordinary profit      23.267 billion yen (+1.3%)
Net profit            3.466 billion yen (-75.5%)
EPS                     26.87 yen

Sales are close to 500 billion yen, but operating margin remained around 4.4% and net profit fell sharply.

For beverage stocks, raw materials, logistics, promotion, weather, FX, and overseas subsidiaries all matter. With a large revenue base, a small margin decline can have a large profit impact.

Today’s Ito En release should be read as a check on whether profit margin can recover, not simply as reassurance from scale.

Ito En individual earnings memo

ETFs: Japan Equities And Rate Hedges

The four ETF releases are read through net assets, NAV, units outstanding, and distributions rather than corporate profit.

ETFNet assetsNAVUnit movementView
NF Enterprise Value (1480)15.690 billion yen36,814 yenFlatPrice gains supported asset growth
JGB Double Inverse (2251)6.246 billion yen86,751 yen per 100 unitsUnits rose from 3.6 million to 7.2 millionRate-rise and JGB futures downside hedge demand
NF Japan Equity Women Empowerment (2518)14.395 billion yen214,652 yen per 100 unitsSlight increaseTheme ETF remained firm
Japan Equity Select ETF (2643)2.038 billion yen393,431 yen per 100 unitsDownPrice rose but money appeared to leave

The clearest signal was the JGB Double Inverse ETF. Net assets rose from 2.919 billion yen to 6.246 billion yen, and units outstanding doubled.

This is different from inflows into a high-dividend equity ETF. A double-inverse JGB product reacts strongly to the downside of JGB futures and can reflect demand to hedge rising rates or falling bond prices. It is not a simple long-term holding tool, and daily compounding effects can create tracking differences.

Correction Disclosures: Heavy And Light Cases Mixed

There were 8 correction disclosures. Headlines can all look serious, but the actual impact differs.

NameCorrectionImpact on earnings assessment
Redax (7602)Additional expense recognition; operating profit, ordinary profit, net profit, EPS revised downSomewhat heavy
MUSCAT GROUP (195A)794 million yen impairment loss on affiliate shares; operating CF correctedHeavy
Kandenko (1942)Comprehensive income aggregation correctionMajor profit figures unchanged
Trade Works (3997)Reclassification of capital surplus and non-controlling interestsNo P/L impact
Softtex (550A)Review of receivables and contract liabilitiesMainly balance sheet
Geniee (6562)Review of revenue recognition, securities, FX itemsHeavy; profit and EPS revised down
Japan Material (6055)Segment description correctionFinancial figures unchanged

The names to watch are Geniee, MUSCAT GROUP, and Redax.

Geniee’s corrected figures showed revenue of 13.376 billion yen, operating profit of 1.535 billion yen, and profit attributable to owners of 866 million yen. Revenue, operating profit, pre-tax profit, profit, and EPS all declined from the original disclosure. This is heavier than a simple display error.

MUSCAT GROUP recorded a 794 million yen impairment loss on affiliate shares in non-consolidated results. Corrected operating cash flow was negative 676 million yen and investing cash flow was negative 484 million yen. The focus should be cash outflow and parent-company capital impairment, not only sales growth.

Redax kept sales unchanged at 19.846 billion yen, but operating profit, ordinary profit, net profit, and EPS were revised down after reviewing the timing of cost of sales and SG&A recognition.

Kandenko and Japan Material, by contrast, did not change major profit figures. Not every “correction” headline carries the same weight.

How To Read The Day

This was not a day of large headline surprises. It was a day to classify the quality of releases.

Ito En
→ Sales grew, but profit did not. Watch margin and net profit decline.

People
→ Q1 loss remained, but loss narrowed. Seasonality matters.

ETFs
→ Japan equity theme ETFs rose; JGB Double Inverse units doubled.

Corrections
→ Geniee and MUSCAT GROUP are heavy. Redax also revised profit down. Kandenko and Japan Material are limited.

On days like this, it is more practical to classify normal earnings, ETF results, light corrections, and heavy corrections than to search for a single “winner.”

Points To Check Next

Ito En needs to explain the sharp fall in net profit. If margins and cash do not recover, sales growth alone is unlikely to receive a strong valuation.

For Geniee and Redax, the market will need to re-price corrected profit levels. Investors who focused only on sales growth may treat accounting-process reviews and additional expense recognition as more serious.

For ETFs, the doubling of JGB Double Inverse units should be watched as a sign of rate-rise caution, while avoiding over-interpreting one ETF as a full bond-market signal.

For companies with correction disclosures, the next earnings release should be checked for explanations of internal controls, accounting treatment, and disclosure processes. After numbers are corrected, the market asks whether recurrence is prevented.

Conclusion

Ito En was the main regular operating-company release, but the content was not a simple positive because it was sales up and profit down. People remained in Q1 loss but narrowed the deficit. ETF releases showed different flows: 1480 and 2518 had NAV gains, 2251 had doubled units, and 2643 had fewer units despite a higher NAV.

Among corrections, Geniee, MUSCAT GROUP, and Redax were heavy. Kandenko, Trade Works, Softtex, and Japan Material had more limited impact on major profit figures in several cases.

The lesson is to read quality, not quantity. Separating regular earnings, ETFs, light corrections, and heavy corrections makes the day much clearer.

Sources

This article is based on earnings releases and correction disclosures published by the target companies and ETFs as of 18:23 on June 1, 2026.

  • Ito En: FY2026/4 earnings release
  • People: FY2027/1 Q1 earnings release
  • NEXT FUNDS ETF annual and interim reports
  • Correction disclosures from Redax, MUSCAT GROUP, Kandenko, Trade Works, Softtex, Geniee, and Japan Material
This article is for educational and informational purposes only, based on public information. It is not a recommendation or solicitation to buy or sell any specific security or financial product. Although care is taken with accuracy, the content and future investment outcomes are not guaranteed. Final investment decisions should be made at your own judgment and responsibility.